The Readout Loud

Latest Episodes:

Episode 138: The latest Covid-19 vaccine, Biden's pandemic plans, and Bill Gates unfiltered Nov 19, 2020

Show notes

How do we measure whether Covid-19 vaccines work? What does Joe Biden think of the drug industry? And does Anthony Fauci think about retirement?

Episode 137: Natalie Dean on Pfizer's Covid-19 vaccine, plus the FDA's Alzheimer's quandary Nov 12, 2020

Show notes

How well does Pfizer's Covid-19 vaccine work? What's the difference between efficacy and effectiveness? And should the FDA approve Biogen's Alzheimer's drug?

Bracing for a pandemic winter, Biogen's fortune at the FDA, and remembering a remarkable 12-year-old Nov 05, 2020

Show notes

How bad will this winter be? Is everything coming up Biogen? And who's going to be president on Jan. 20? We discuss all that and more on this week's episode of “The Readout LOUD,” STAT's biotech podcast. First, STAT's Helen Branswell joins us to discuss what the winter has in store for the ongoing Covid-19 pandemic. Then, we discuss the latest surprising twist in Biogen’s quest to win FDA approval for a polarizing treatment for Alzheimer’s disease. Finally, STAT reporter Casey Ross joins to talk about the recent death and legacy of Bertrand Might, a 12-year boy born with a rare genetic disease.

Episode 135: Pfizer's Covid-19 mystery, Ashish Jha on pandemic response, & STAT turns 5 Oct 29, 2020

Show notes

When are we getting Covid-19 vaccine data? Will concerts ever be safe again? And what's a "Bionomy"?

Episode 134: Erik Gordon on SPACs, plus Covid-19 vaccines, & Biogen's case in Alzheimer's Oct 22, 2020

Show notes

Who's voice rings loudest at the FDA? Is it wise to give hedge funds a blank check? And how will the Biogen saga end?

Episode 133: A week of pauses, pharma’s statehouse spending, & how HBCUs approach Covid-19 trials Oct 15, 2020

Show notes

Is your local lawmaker flush with pharma cash? How does racism in medicine loom over Covid-19 studies? And who decides when a clinical trial goes on pause?

Episode 132: How Trump's case of Covid-19 affects biotech, medicine, and the FDA with George Scangos Oct 08, 2020

Show notes

Why is the president making drug ads? Are antibodies the new vaccines? And is it ethical for doctors to talk about President Trump's health?

Episode 131: Saad Omer on Covid-19 vaccine trials, & Ethan Weiss on intermittent fasting Oct 01, 2020

Show notes

Can an itchy arm ruin a clinical trial? Does intermittent fasting work? And is pharma more trustworthy than the CDC?

Episode 130: A road map for Covid-19, the gold rush in health tech, & D.C.'s pandemic unrest Sep 24, 2020

Show notes

Is superspreading an Olympic event? Will Covid-19 forever change health tech? And what are the limits of Anthony Fauci's patience?

Episode 129: Heidi Tworek on pandemic PR, plus the CDC's credibility crisis & a lightning round Sep 17, 2020

Show notes

How should governments talk about Covid-19? Can the Centers for Disease Control and Prevention rebuild public trust? And when is a steak worth $21 billion?

Our TOPPODCAST Picks

Follow Us

Stay Connected

Related Podcasts

Links

Stay Connected

Our TOPPODCAST Picks

Follow Us

Stay Connected

The Readout Loud

Related Podcasts

1

2

3

4

5

6